New software predicts CVD risk better than Framingham
QRISK2 uses a new cardiovascular disease equation to estimate an individual’s ten-year CVD risk using analysis of 15 years’ worth of real primary care data. The software is the result of a not-for-profit partnership between the University of Nottingham and primary care system supplier EMIS.
Unlike the traditional Framingham risk score, QRISK2 takes into account the higher risk of developing CVD to patients from deprived areas and from certain ethnic groups. It also considers other risk factors, including whether the patient already suffers from a pre-existing condition such as diabetes.
Professor Julia Hippisley-Cox, from the University of Nottingham’s division of primary care, said: ‘We believe this formula has the potential to save many thousands of lives, by helping clinicians to more accurately predict those at risk of developing cardiovascular disease – the nation’s biggest killer.’
The QRISK2 software will be incorporated into existing EMIS clinical records systems – used by 56% of GP surgeries in the UK. It will support Government plans for a£250 million national cardiovascular screening programme, which will offer checks to everyone between the ages of 40 and 70.
Related article on nursingtimes.net: Key role for nurses in CVD prevention